other material
confidence high
sentiment neutral
materiality 0.60
Biostage shareholders approve reverse stock split ratio of 1-for-1.25 to 1-for-5
Harvard Apparatus Regenerative Technology, Inc.
- Proposal to amend charter to effect reverse stock split approved with 7,072,052 votes for, 196,116 against, 742 abstained.
- Board retains discretion to choose final ratio between 1:1.25 and 1:5 and to set timing within one year.
- Special meeting held July 28, 2022; result filed August 2, 2022.